Lifileucel: First Approval

This article summarizes the milestones in the development of lifileucel leading to this first approval for the treatment of patients with unresectable or metastatic melanoma who have progressed on or after prior anti-PD-1/L1 therapy and targeted therapy.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research